May 17, 2023 / 12:00PM GMT
Greg Renza - RBC Capital Markets - Analyst
Well, good morning, everyone, and welcome to day two of the 2023 RBC Global Healthcare Conference. My name is Greg Renza, one of the biotechnology equity research analysts here at RBC, and we're pleased to have Aptose Biosciences with us this morning. And joining us from the company is Dr. William Rice, the Chairman, President and Chief Executive Officer.
Bill, it's great to see you, and thanks for being here.
William Rice - Aptose Biosciences Inc. - Chairman of the Board, President, & CEO
You too, Greg. Thank you so much for the invitation to your conference, and it's actually wonderful to see everyone face-to-face again. And so, thanks again for having us here.
Greg Renza - RBC Capital Markets - Analyst
Absolutely. Makes a big difference. And it's always great to connect on your portfolio. A great deal going on with tuspetinib, and we always look forward to the data updates that you generate with the program and for patients every few times a year investment.
Aptose Biosciences Inc at RBC Capital Markets Global Healthcare Conference Transcript
May 17, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers